Mifepristone abortion outside the urban research hospital setting in India (HTML)
Coyaji,Kurus; Elul,Batya; Krishna,Usha; Otiv,Suhas; Ambardekar,Shubha; Bopardikar,Arti; Raote,Veena; Ellertson,Charlotte; Winikoff,Beverly
Lancet 357(9250): 120-121
Publication date: 2001
Medical abortion holds great promise in less-developed countries, where abortion morbidity and mortality remain high. We tested the French mifepristone-misoprostol regimen in two urban outpatient family-planning clinics (n=600) and a rural hospital (n=300) in India. 4% of urban women and 1% of rural women were lost to follow-up. Perfect use and typical-use success rates were as high as European rates at all sites. Although rural women reported fewer side-effects, most women in urban and rural settings were satisfied with their medical abortions. Medical abortion can be offered safely, effectively, and acceptably in urban outpatient clinics and rural hospitals in India.
For 60 years, the Population Council has changed the way the world thinks about important health and development issues. Explore an interactive timeline of the Council's history, learn more about some of our key contributions, and watch a short video about why your support is so important to us.